In vitro release of eosinophil proteins in allergic and atopic dermatitis patients
1994

Eosinophil Protein Release in Allergic Conditions

Sample size: 31 publication Evidence: moderate

Author Information

Author(s): L. K. Poulsen, C. M. Reimert, C. Bindslev-Jensen

Primary Institution: National University Hospital, Medical Department, Allergy Unit, Copenhagen, Denmark

Hypothesis

Are eosinophils stimulated in vivo or do they have increased susceptibility to stimuli from the coagulation cascade?

Conclusion

Eosinophils in patients with atopic dermatitis release significantly more eosinophil cationic protein during clotting compared to allergic and non-allergic individuals.

Supporting Evidence

  • Eosinophil cationic protein levels were significantly higher in serum than in plasma.
  • The atopic dermatitis group had a serum-to-plasma ratio of 13.5 for ECP.
  • Correlations were found between eosinophil counts and serum levels of ECP and EPX.

Takeaway

This study found that people with atopic dermatitis have more eosinophil proteins in their blood when it clots compared to those without allergies.

Methodology

The study compared eosinophil protein release from three groups of donors with varying serum IgE levels using blood samples.

Limitations

The study did not determine the activation state of eosinophils in the blood of patients.

Participant Demographics

Participants included 11 with atopic dermatitis, 10 with inhalant allergy, and 10 non-allergic individuals, with similar age profiles and sex distributions.

Statistical Information

P-Value

p<0.003

Statistical Significance

p<0.003

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication